Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
07.05.24
/
50%
€4.98
Target price
07.05.25
€11.13
Performance (%)
37.18%
Price
27.09.24
€6.83
Summary
This prediction is currently active. With a performance of 37.18% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 07.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biocryst Pharmaceuticals | -6.898% | -6.898% |
iShares Core DAX® | 1.518% | 3.456% |
iShares Nasdaq 100 | 1.240% | 2.983% |
iShares Nikkei 225® | 2.808% | 2.743% |
iShares S&P 500 | 0.403% | 2.187% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
13.83%
27.09.24
27.09.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
19.82%
27.09.24
27.09.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.47
03.08.23
03.08.23
€10.96
03.08.24
03.08.24
-1.24%
04.08.24
04.08.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24